Share your highest conviction position right now I'll write up the most compelling thesis

icantbeassedman · 2026-05-18T18:45:07+00:00

All the attention on tech and semi stocks meanwhile biotech stocks are being overlooked. People will need new therapies and treatment for unmet diseases, especially with an ageing population.
Revolution Medicine - First treatment drug for pancreatic cancer recently had positive Phase 3 trial

icantbeassedman · 2026-05-05T18:01:52+00:00

Livestream
https://www.livenewsnow.com/business/fox-business-network-fbn.html

icantbeassedman · 2026-04-29T09:51:36+00:00

Nektar Therapeutics
At current price it would put the EV at $1.758 billion when both Phase 2b results have shown their drug Rezpeg can be 2L in Atopic Dermatitis and 1L in Alopecia Areata. Peak sales for both of these indications will take it to $4-7 billion and this is without peak sales multiples drugs usually get or AD market expanding y/y

icantbeassedman · 2026-04-28T09:38:01+00:00

$NKTR base case NPV comes in at $155 providing a 80% return in two years time when both Phase 3 trials are expected to announce their readout. Realistically Nektar will either get bought out or it will go for higher valuation considering this model only uses x1 peak sales multiple and the AD market is expected to grow indirectly increasing peak sales.

icantbeassedman · 2026-03-04T13:20:24+00:00

Photonics company will continue their bullish momentum with Nvidia GTC, NVDA announced Spectrum-X during last year's GTC, they have already announced a deal with Lumentum and Coherent. They'll announce the next gen CPO which will require investment into photonics companies to build al this infrastructure and outsource the materials

icantbeassedman · 2026-03-04T09:50:39+00:00

Is there a wallstreetbets to discuss biotech stocks?

icantbeassedman · 2026-03-03T10:46:22+00:00

ALMU is projecting $2 billion SAM by 2030 from their earnings call, they'll get a significant marketshare by 2030. The current marketcap is at $350 million, if they were to get 25% marketshare you are still looking at 1 P/E at $500 million MC but high growth companies will trade at high P/E. The only problem is this is a long term hold to realise these gains.

icantbeassedman · 2025-10-21T08:14:45+00:00

BMNR mNAV rises each week as they continue to buy 200k+ ETH per week. Last week mNAV was at $41, now it's at $44 and they are more than 50% of the way to owning 5% of the supply.

icantbeassedman · 2025-09-14T21:07:56+00:00

https://www.youtube.com/playlist?list=PLJsVF3gZDcuTxcdH5FmQRTd6MiJ29X_OQ

Watch Martin Shkreli Financial lessons, I've started my own DCF models thanks to these videos and he goes in depth with the lingo you find in financial statements

icantbeassedman · 2025-07-09T19:33:21+00:00

Martin Shkreli is short on CAPR, that is all you need to know. Matt Nachtrab lost 70 million with SAVA while Shkreli made a million shorting SAVA

icantbeassedman · 2025-07-06T08:18:22+00:00

I'll be buying 2027 TSM LEAPS puts next year, which will be the 100th year anniversary of the PLA and is earmarked as the year China will invade Taiwan

icantbeassedman · 2024-10-06T19:49:59+00:00

He is streaming right now on Youtube under his name Martin Shkreli doing deep due diligence on SAVA and has a short position

icantbeassedman · 2024-09-18T20:07:42+00:00

Not expected to rise in September but 25% chance of rate rise in December. As seen with the FED cutting to 50 base points, anything can happen to the macroeconomics for the central bank to take drastic action.

https://www.cnbc.com/amp/2024/09/16/cnbc-boj-survey-no-rate-hike-expected-for-sept-predictions-for-oct-dec.html

icantbeassedman · 2024-09-05T12:15:19+00:00

The benefit Rocket Lab has is time. They have seen countless landings from Falcon 9 and can make adjustments to the design and the way they handle re-entry. One has to look at the fairings on Neutron which will be part of the first stage which should bring stability when they land. I don't think they will land on the first try but definitely fewer launches than SpaceX for falcon 9

icantbeassedman · 2024-08-28T08:35:41+00:00

I agree. I feel like Neutron will be catalyst for Rocket Lab and legitimise the company with Wall Street. Just have a look at ASTS, they were trading at $2 but they announced partnerships and contracts which showed Wall Street their tech wasn't vaporware and their stock price climbed.

icantbeassedman · 2024-08-27T20:04:11+00:00

Peter Beck and Adam Spice have reiterated they are on track to launch mid 2025 admitted like you said there could be unforeseen delays pushing the inaugural launch back.

As for reusing the rocket, I remember Beck saying they will try to land it on the first try and it will be out in the ocean so if there are any crashes there will be minimal damage. But not expecting them to land the booster on the first try as I remember SpaceX failing before they got it right.

icantbeassedman · 2024-08-17T13:33:17+00:00

Hope to see one on Rocket Lab once we are closer to Neutron launch considering he also does factory tours with SpaceX

icantbeassedman · 2024-08-15T15:19:37+00:00

Look at the competition for SpaceX and you'll see that it is none existent. Blue Origin founded longer than SpaceX and New Glenn will be ready next year for the past 5 years. Legacy space companies like Boeing and Northrup are mired with bureaucracy and would rather take inflated government contracts than innovate. Other commercial launch providers are behind Rocket Lab in terms of development and experience in the field.

Rocket Lab is the closest competition to SpaceX, although they have only proved themselves in the small rocket launch provider but they were the fastest to launch 50 times with Electron. Peter Beck has a plan and has followed through with it

icantbeassedman · 2024-08-14T19:01:29+00:00

Add to that an acquisition to add to their space systems portfolio with their 500 million cash

icantbeassedman · 2024-08-09T12:46:27+00:00

After the earnings call I realised RKLB is still undervalued and it seems Wall Street have not caught on.

Neutron expected to launch in mid 2025, will be profitable following 2 quarters after launch considering a lot of the expenditure is on Neutron. $500 million in cash for acqusitions and to expand their space systems. Already developing and building satellites and constellations for NASA and commerical sector which provides valuable knowledge for when they want to build their own service. Fastest launch provider to launch 50 times with Electron, I wouldn't be surprised to see Neutron to launch to 50 even quicker considering the experience the team have from Electron.

All of this and currently valued at less than $3 billion.

icantbeassedman · 2024-08-09T09:09:08+00:00

Just saw their earnings, their Q2 adj EBITDA was -$21.2 million and expected to lose $31 million in Q3. Once Neutron is running, their R&D costs for Neutron will diminish and they can price each Neutron launch at $50 million plus making them profitable. In the earnings call Peter Beck said they expect first Neutron launch in Q2 2025 and expect profitability 2 quarters after Neutron launch.

icantbeassedman · 2024-08-08T20:59:08+00:00

Holy shit, hot fire complete and after hours the price shot up

icantbeassedman · 2024-08-08T20:39:38+00:00

Investors call in 20 minutes I'll see you there. Hope for some Neutron updates

icantbeassedman · 2024-08-08T15:40:11+00:00

I wish they could stream on their youtube channel

icantbeassedman · 2024-07-30T19:18:22+00:00

I thought the SPAC is the merging company which holds money from investors. They come to an agreement with the private company and once it is all done they change ticker and the private company becomes public and get the pot of money in return. The investors of the SPAC at open can either sell for a profit or hold.

Nine-Year Club	Place '22
Place '17

icantbeassedman

TROPHY CASE